These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 7340712

  • 21. [Computer-assisted screening for cervical carcinoma--the results for a 10-year period].
    Neumann HG, Seidenschnur G.
    Arch Geschwulstforsch; 1987; 57(2):129-39. PubMed ID: 3296989
    [Abstract] [Full Text] [Related]

  • 22. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
    Misra JS, Gupta HP, Das V.
    Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
    [Abstract] [Full Text] [Related]

  • 23. [Effectiveness of cervical screening - expectation and reality].
    Kostova P, Zlatkov V.
    Akush Ginekol (Sofiia); 2000 Dec; 39(3):23-4. PubMed ID: 11187989
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of cervical cancer screening in Scandinavia.
    Day NE.
    Obstet Gynecol; 1984 May; 63(5):714-8. PubMed ID: 6717876
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of a hospital based cytology screening programme for reduction in life time risk of cervical cancer.
    Agarwal SS, Murthy NS, Sharma S, Sharma KC, Das DK.
    Neoplasma; 1995 May; 42(2):93-6. PubMed ID: 7617084
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of mass screening for cervical cancer in Shiga Prefecture].
    Ishiguro T, Yoshida Y, Tenzaki T, Tanaka B.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):655-60. PubMed ID: 6864024
    [Abstract] [Full Text] [Related]

  • 30. [Methodologic and organizational principles of selective screening for cervical, endometrial and ovarian carcinoma].
    Zalutskiĭ IV, Vishnevskaia EE, Kurian LM.
    Vopr Onkol; 2006 May; 52(1):74-7. PubMed ID: 16715709
    [Abstract] [Full Text] [Related]

  • 31. [A result of mass-screening for uterine cervical cancer in Hyogo prefecture (author's transl)].
    Hasegawa K, Miyazaki Y, Kitaura Y, Ohtsu F, Takeuchi K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Dec; 33(12):2097-104. PubMed ID: 7338662
    [Abstract] [Full Text] [Related]

  • 32. [Studies of screening, detection and mortality rates in mass screening for uterine cervical cancer in Shimane prefecture].
    Takahashi K, Moriyama M, Takamiya O, Shibukawa T, Iwanari O, Matsunaga I, Kitao M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):377-82. PubMed ID: 3981047
    [Abstract] [Full Text] [Related]

  • 33. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF, Werner B, Totsugui J, Collaço LM, Araújo SR, Huçulak M, Boza EJ, Fischer RM, De Laat L, Sobbania LC, Raggio A.
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [Abstract] [Full Text] [Related]

  • 34. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK, Ngan HY, Chu TY, Cheung AN, Tay EH.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [Abstract] [Full Text] [Related]

  • 35. [Results of a mass screening program of cervix carcinoma of the city of Wismar].
    Schrodt U, Sauer C.
    Zentralbl Gynakol; 1977 Aug 19; 99(17):1033-6. PubMed ID: 919878
    [Abstract] [Full Text] [Related]

  • 36. Changes of morbidity and mortality from cancer of the cervix uteri in Puerto Rico.
    Martínez I.
    Bol Asoc Med P R; 1984 Mar 19; 76(3):100-6. PubMed ID: 6586182
    [No Abstract] [Full Text] [Related]

  • 37. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.
    J Natl Cancer Inst; 2008 May 07; 100(9):622-9. PubMed ID: 18445828
    [Abstract] [Full Text] [Related]

  • 38. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK.
    APMIS Suppl; 1998 May 07; 80():1-41. PubMed ID: 9693662
    [Abstract] [Full Text] [Related]

  • 39. [Evaluation of mass-screening for cervical cancer in Santo-Cho. Effect of repeat cytological screening].
    Ishiguro T, Yoshida Y, Tenzaki T, Matsumoto J.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jun 07; 35(6):814-8. PubMed ID: 6875334
    [Abstract] [Full Text] [Related]

  • 40. Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31031 women from the Bonn-region in West Germany.
    Bollmann R, Bankfalvi A, Griefingholt H, Trosic A, Speich N, Schmitt C, Bollmann M.
    Oncol Rep; 2005 May 07; 13(5):915-22. PubMed ID: 15809758
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.